Study to evaluate the effectiveness and safty of the mFOLFOX+bevacizumab combination therapy for bladder adenocarcinoma
Latest Information Update: 12 Oct 2020
At a glance
- Drugs Bevacizumab (Primary) ; Fluorouracil; Levofolinic acid; Oxaliplatin
- Indications Bladder cancer
- Focus Therapeutic Use
- 08 Oct 2020 Status changed from recruiting to completed.
- 31 May 2016 New trial record